Legend Biotech (LEGN) Current Deferred Revenue (2019 - 2026)
Legend Biotech (LEGN) recorded Current Deferred Revenue of $700,000 in Q2 2026, down 97.9% from $33.18 million a year earlier and down 88.3% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Current Deferred Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025, Legend Biotech reported Current Deferred Revenue of $11.3 million, down 75.9% from FY2024.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $46.9 million in FY2024 (-11.5%), $53.01 million in FY2023 and $60.64 million in FY2021 (+10.2%).
- The Q2 2026 figure is the lowest quarterly Current Deferred Revenue in data going back to Q4 2019.
- On a year-over-year basis, Current Deferred Revenue has declined for seven consecutive quarters, with an average decline of 61.1% over the last seven quarters.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 20.4% in Q1 2022, against a decline of 97.9% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6 million (Q1 2026), $11.3 million (Q4 2025) and $22.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Legend Biotech | 3.42 Bn | 924.58 Mn | 251.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 11.30 Mn |
| Sep 30, 2025 | 22.58 Mn |
| Jun 30, 2025 | 33.18 Mn |
| Mar 31, 2025 | 39.54 Mn |
| Dec 31, 2024 | 46.90 Mn |
| Sep 30, 2024 | 63.16 Mn |
| Jun 30, 2024 | 74.85 Mn |
| Mar 31, 2024 | 63.25 Mn |
| Dec 31, 2023 | 53.01 Mn |
| Mar 31, 2022 | 65.56 Mn |
| Dec 31, 2021 | 60.64 Mn |
| Sep 30, 2021 | 55.82 Mn |
| Jun 30, 2021 | 56.14 Mn |
| Mar 31, 2021 | 54.46 Mn |
| Dec 31, 2020 | 55.01 Mn |
| Sep 30, 2020 | 46.79 Mn |
| Jun 30, 2020 | 46.31 Mn |
| Dec 31, 2019 | 46.29 Mn |
API Access
Legend Biotech Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();